These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12044318)

  • 1. Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies.
    Heikkilä A; Makkonen N; Heinonen S; Kirkinen P
    Hypertens Pregnancy; 2001; 20(1):99-106. PubMed ID: 12044318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
    Gravett CP; Buckmaster JG; Watson PT; Gravett MG
    Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
    Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
    Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of human chorionic gonadotrophin in very early pregnancy and subsequent pre-eclampsia: a cohort study.
    Asvold BO; Vatten LJ; Tanbo TG; Eskild A
    Hum Reprod; 2014 Jun; 29(6):1153-60. PubMed ID: 24722241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
    Chen Y; Dai X; Wu B; Jiang C; Yin Y
    BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
    Ganapathy R; Lamont RF; Bassett P
    Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can serum HCG values be used in the differential diagnosis of pregnancy complicated by hypertension?
    Gurbuz A; Karateke A; Mengulluoglu M; Gedikbasi A; Ozturkmen M; Kabaca C; Sahinoglu Z
    Hypertens Pregnancy; 2004; 23(1):1-12. PubMed ID: 15117595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin, fetal sex and risk of hypertensive disorders of pregnancy: A nested case-control study.
    Zheng Q; Deng Y; Zhong S; Shi Y
    Pregnancy Hypertens; 2016 Jan; 6(1):17-21. PubMed ID: 26955766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
    Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
    Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
    Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia.
    Keikkala E; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    Placenta; 2013 Nov; 34(11):1059-65. PubMed ID: 23993394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome.
    Onderoğlu LS; Kabukçu A
    Int J Gynaecol Obstet; 1997 Mar; 56(3):245-9. PubMed ID: 9127156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
    J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.